{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:25:05Z","timestamp":1792056305606,"version":"4.4.0"},"reference-count":108,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2006,8,10]]},"abstract":"<jats:p>Human cancers exhibit genomic instability and an increased mutation rate due to underlying defects in DNA repair. Cancer cells are often defective in one of six major DNA repair pathways, namely: mismatch repair, base excision repair, nucleotide excision repair, homologous recombination, nonhomologous endjoining and translesion synthesis. The specific DNA repair pathway affected is predictive of the kinds of mutations, the tumor drug sensitivity, and the treatment outcome. The study of rare inherited DNA repair disorders, such as Fanconi anemia, has yielded new insights to drug sensitivity and treatment of sporadic cancers, such as breast or ovarian epithelial tumors, in the general population. The Fanconi anemia pathway is an example of how DNA repair pathways can be deregulated in cancer cells and how biomarkers of the integrity of these pathways could be useful as a guide to cancer management and may be used in the development of novel therapeutic agents.<\/jats:p>","DOI":"10.1200\/jco.2005.05.4171","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T20:13:50Z","timestamp":1155068030000},"page":"3799-3808","source":"Crossref","is-referenced-by-count":250,"title":["DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes"],"prefix":"10.1200","volume":"24","author":[{"given":"Richard D.","family":"Kennedy","sequence":"first","affiliation":[{"name":"From the Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"D'Andrea","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1038\/25292"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.07.009"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1038\/nature03482"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1038\/35077232"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.001776"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Zhang X, Miao X, Liang G, et al: Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65:722,2005-726,","DOI":"10.1158\/0008-5472.722.65.3"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi318"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.2594"},{"key":"R10","unstructured":"Stoehlmacher J, Ghaderi V, Iobal S, et al: A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 21:3075,2001-3079,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj135"},{"key":"R12","unstructured":"Robertson KA, Bullock HA, Xu Y, et al: Altered expression of Ape1\/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 61:2220,2001-2225,"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0715"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2005.01.005"},{"key":"R15","unstructured":"Aebi S, Kurdi-Haidar B, Gordon R, et al: Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56:3087,1996-3090,"},{"key":"R16","unstructured":"Kane MF, Loda M, Gaida GM, et al: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808,1997-811,"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.7.735"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<590::AID-IJC23>3.0.CO;2-O"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0513"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2003.09.010"},{"key":"R21","unstructured":"Furuta T, Ueda T, Aune G, et al: Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res 62:4899,2002-4902,"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0247"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088759"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.735"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2502"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2004.03.004"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11087-7"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1457"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4861"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16774"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00408-7"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(99)80311-X"},{"key":"R33","unstructured":"Rigas B, Borgo S, Elhosseiny A, et al: Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Cancer Res 61:8381,2001-8384,"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1510"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10807"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-7864(02)00006-X"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306500200"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2005.02.007"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0603"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1214"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.3.214"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308717101"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Couch FJ, Johnson MR, Rabe K, et al: Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res 65:383,2005-386,","DOI":"10.1158\/0008-5472.383.65.2"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63329-9"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000009274"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403280"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.7.564"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1038\/362709a0"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.34.1.359"},{"key":"R52","unstructured":"Fink D, Aebi S, Howell SB: The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1,1998-6,"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90331-J"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(99)80046-7"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206096"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1038\/85798"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.747"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00174-5"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00175-7"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.15.5214-5222.2001"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.00162.x"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf534"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.03.032"},{"key":"R64","unstructured":"Wang J, Kawamura K, Tada Y, et al: DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res 61:5366,2001-5369,"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1370505"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2025"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1038\/21447"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(03)00189-1"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203454"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc970"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1038\/ng1241"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00173-3"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1038\/ng1627"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1038\/ng1625"},{"key":"R75","doi-asserted-by":"crossref","unstructured":"Levran O, Attwooll C, Henry RT, et al: The BRCA1-interacting helicase BRIP1 is deficient in Fanconi Anemia. Nat Genet 39:931,2005-933,","DOI":"10.1038\/ng1624"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.004"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.08.009"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2170"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(91)90002-C"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11046"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg072"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1970"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.129.1.106"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.4.820"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-3-33"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0245"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207256"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-3-16"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1038\/nm852"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1187"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-2-24"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02450.x"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.18.1396"},{"key":"R94","unstructured":"Yuan SS, Lee SY, Chen G, et al: BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res 59:3547,1999-3551,"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102223440801"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207677"},{"key":"R97","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01115-X"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh260"},{"key":"R99","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11310"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.8.608"},{"key":"R101","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0278"},{"key":"R102","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1048"},{"key":"R103","doi-asserted-by":"publisher","DOI":"10.1038\/ng1297-479"},{"key":"R104","unstructured":"Calabrese CR, Batey MA, Thomas HD, et al: Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. Clin Cancer Res 9:2711,2003-2718,"},{"key":"R105","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80276-2"},{"key":"R106","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(99)80118-3"},{"key":"R107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.035"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.6.1456"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.05.4171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T08:47:23Z","timestamp":1683535643000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.05.4171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,10]]},"references-count":108,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2006,8,10]]}},"alternative-id":["10.1200\/JCO.2005.05.4171"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.05.4171","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,10]]}}}